Oncotarget · 2017 · 38 citations · 23 references
MedicineOncologySurgeryGastrointestinal OncologyMetastasisSurgical OncologyBiliary Tract CancerHepatobiliary CancerLiver CancerPreoperative Oncology AssessmentPreoperative Risk AssessmentSurvival OutcomesCut PointsEarly Detection Of RecurrenceEarly Recurrence DetectionEarly Recurrence PredictionLymph Node Metastasis BiomarkersLymph Node Metastasis PrognosisPositive Predictive ValuePrognostic Factors Analysis
// Jun-Ke Wang 1, * , Hai-Jie Hu 1, * , Anuj Shrestha 1, 2 , Wen-Jie Ma 1 , Qin Yang 1 , Fei Liu 1 , Nan-Sheng Cheng 1 , Fu-Yu Li 1 1 Department of Biliary Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan Province, China 2 Department of General Surgery, Gandaki Medical College, Pokhara, Nepal * These authors contributed equally to this work Correspondence to: Fu-Yu Li, email: lfy_74@hotmail.com Keywords: hilar cholangiocarcinoma, CA19-9, prognosis, early recurrence Received: October 07, 2016 Accepted: April 11, 2017 Published: April 21, 2017 ABSTRACT Background: To investigate the predictive values of preoperative and postoperative serum CA19-9 levels on survival and other prognostic factors including early recurrence in patients with resectable hilar cholangiocarcinoma. Results: In univariate analysis, increased preoperative and postoperative CA19-9 levels in the light of different cut-off points (37, 100, 150, 200, 400, 1000 U/ml) were significantly associated with poor survival outcomes, of which the cut-off point of 150 U/ml showed the strongest predictive value (both P < 0.001). Preoperative to postoperative increase in CA19-9 level was also correlated with poor survival outcome ( P < 0.001). In multivariate analysis, preoperative CA19-9 level > 150 U/ml was significantly associated with lymph node metastasis (OR = 3.471, 95% CI 1.216–9.905; P = 0.020) and early recurrence (OR = 8.280, 95% CI 2.391–28.674; P = 0.001). Meanwhile, postoperative CA19-9 level > 150 U/ml was also correlated with early recurrence (OR = 4.006, 95% CI 1.107–14.459; P = 0.034). Materials and Methods: Ninety-eight patients who had undergone curative surgery for hilar cholangiocarcinoma between 1995 and 2014 in our institution were selected for the study. The correlations of preoperative and postoperative serum CA19-9 levels on the basis of different cut-off points with survival and various tumor factors were retrospectively analyzed with univariate and multivariate methods. Conclusions: In patients with resectable hilar cholangiocarcinoma, serum CA19-9 predict survival and early recurrence. Patients with increased preoperative and postoperative CA19-9 levels have poor survival outcomes and higher tendency of early recurrence.
23
Staging, Resectability, and Outcome in 225 Patients With Hilar Cholangiocarcinoma
William R. Jarnagin, Yuman Fong, Ronald P. DeMatteo et al. · Annals of Surgery · 2001 · 1.4K citations
What constitutes long term survival after surgery for hilar cholangiocarcinoma?
J�rgen Klempnauer, Gerd Jürgen Ridder, Martin Werner et al. · Cancer · 1997 · 200 citations · Full text
Liang Liu, Huaxiang Xu, Wenquan Wang et al. · International Journal of Cancer · 2014 · 113 citations · Full text